Trial Profile
An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine in Patients With Preserved Cardiac Output (CO) and an Intravenous Fluid Bolus for Patients With Low CO Following Total Hip Arthroplasty
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2017
Price :
$35
*
At a glance
- Drugs Midodrine (Primary)
- Indications Orthostatic hypotension
- Focus Therapeutic Use
- 20 Jan 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 11 Jul 2014 New trial record